These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22561216)

  • 1. Patient-reported long-term rectal function after permanent interstitial brachytherapy for clinically localized prostate cancer.
    Orio PF; Merrick GS; Galbreath RW; Butler WM; Lief J; Wallner KE
    Brachytherapy; 2012; 11(5):341-7. PubMed ID: 22561216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term rectal function after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Gutman S; Lief J
    Cancer J; 2007; 13(2):95-104. PubMed ID: 17476137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Cleavinger S
    Brachytherapy; 2003; 2(3):147-57. PubMed ID: 15062137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal function following prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Galbreath RW; Blatt H; Lief JH
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):667-74. PubMed ID: 11020562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapy.
    Merrick GS; Butler WM; Wallner KE; Murray BC; Allen Z; Galbreath RW
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):68-74. PubMed ID: 14697422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late rectal function after prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Hines AL; Allen Z
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):42-8. PubMed ID: 12909214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
    Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
    Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the impact of isotope ((125)I vs. (103)Pd) on toxicity and biochemical outcome after interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer.
    Kollmeier MA; Pei X; Algur E; Yamada Y; Cox BW; Cohen GN; Zaider M; Zelefsky MJ
    Brachytherapy; 2012; 11(4):271-6. PubMed ID: 22192495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer.
    Sherertz T; Wallner K; Merrick G; Ford E; Sutlief S; Cavanagh W; Butler W; True L
    Brachytherapy; 2004; 3(3):130-5. PubMed ID: 15533804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
    Forsythe K; Blacksburg S; Stone N; Stock RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erectile function after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Stipetich RL; Abel LJ; Lief JH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):893-902. PubMed ID: 11958881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
    Niehaus A; Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Adamovich E
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):136-43. PubMed ID: 16198062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
    Cesaretti JA; Stock RG; Atencio DP; Peters SA; Peters CA; Burri RJ; Stone NN; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1410-6. PubMed ID: 17490827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN; Stock RG
    Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding.
    Akimoto T; Katoh H; Kitamoto Y; Tamaki T; Harada K; Shirai K; Nakano T
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):364-70. PubMed ID: 16690428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
    Wust P; von Borczyskowski DW; Henkel T; Rosner C; Graf R; Tilly W; Budach V; Felix R; Kahmann F
    Radiother Oncol; 2004 Oct; 73(1):39-48. PubMed ID: 15465144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer.
    Taira AV; Merrick GS; Galbreath RW; Butler WM; Lief J; Adamovich E; Wallner KE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e225-32. PubMed ID: 21664066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal function following permanent prostate brachytherapy.
    Merrick GS; Butler WM
    W V Med J; 2004; 100(1):18-20. PubMed ID: 15119492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Allen Z; Adamovich E
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):32-43. PubMed ID: 15629591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.